Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,824 | 71,233 | 65,064 | 88,713 | 109,240 |
| Marketable Securities | 232,056 | 237,639 | 281,337 | 282,419 | 307,990 |
| Receivables | 35,610 | 42,021 | 37,969 | 31,211 | 31,545 |
| Inventories | 13,214 | 13,291 | 14,448 | 19,490 | 18,960 |
| TOTAL | $351,552 | $374,034 | $410,188 | $435,237 | $476,809 |
| Non-Current Assets | |||||
| PPE Net | 55,418 | 65,260 | 68,227 | 76,749 | 79,390 |
| Intangibles | 123,253 | 123,677 | 124,100 | 124,529 | 124,957 |
| Other Non-Current Assets | 54,649 | 57,352 | 58,619 | 81,167 | 83,384 |
| TOTAL | $233,320 | $246,289 | $250,946 | $282,445 | $287,731 |
| Total Assets | $584,872 | $620,323 | $661,134 | $717,682 | $764,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,867 | 12,170 | 7,719 | 4,483 | 9,163 |
| Accrued Expenses | 16,228 | 14,318 | 22,282 | 20,799 | 18,910 |
| Other current liabilities | N/A | N/A | N/A | 3,194 | N/A |
| TOTAL | $88,126 | $82,952 | $88,015 | $93,298 | $95,335 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 52,225 | 46,870 | 48,630 | 55,340 | 57,917 |
| Other Non-Current Liabilities | 216,498 | 218,471 | 220,074 | 218,579 | 222,344 |
| TOTAL | $255,316 | $262,605 | $264,841 | $262,747 | $273,238 |
| Total Liabilities | $343,442 | $345,557 | $352,856 | $356,045 | $368,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,472 | 147,368 | 145,092 | 144,773 | 144,645 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -1,238,061 | -1,191,839 | -1,144,332 | -1,074,891 | -1,024,591 |
| Other shareholders' equity | -355 | -253 | 94 | -345 | -962 |
| TOTAL | $241,430 | $274,766 | $308,278 | $361,637 | $395,967 |
| Total Liabilities And Equity | $584,872 | $620,323 | $661,134 | $717,682 | $764,540 |